Ergotmaine Tartrate
Generic Name: ergotmaine tartrate
Dosage form: POWDER. Active ingredients: ERGOTAMINE TARTRATE (25 kg/25kg). Category: BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING.
Overview
Dosage form: POWDER. Active ingredients: ERGOTAMINE TARTRATE (25 kg/25kg). Category: BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING.
Dosage
Available as powder.
Related Medications
Calendula Officinalis, Symphytum Officinale, Arnica Montana, Bellis Perennis, Hypericum Perforatum, Ledum Palustre, Phosphorus, Rhus Tox, Ruta Graveolens, Staphysagria, Strontium Carbonicum
calendula officinalis, symphytum officinale, arnica montana, bellis perennis, hypericum perforatum, ledum palustre, phosphorus, rhus tox, ruta graveolens, staphysagria, strontium carbonicum
INDICATIONS: May temporarily relieve soreness after exertion, bruises, strains, sprains, and joint pain and stiffness.** **Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
Cevimeline Hydrochloride
cevimeline hydrochloride
DESCRIPTION Cevimeline is cis-2’-methylspiro {1-azabicyclo [2.2.2] octane-3, 5’ -[1,3] oxathiolane} hydrochloride, hydrate (2:1). Its empirical formula is C 10 H 17 NOS.HCl.1/2 H 2 O, and its structural formula is: Cevimeline has a molecular weight of 244.79. It is a white to off white crystalline powder with a melting point range of 201 to 203°C. It is freely soluble in alcohol and chloroform, very soluble in water, and virtually insoluble in ether.
Atrasentan
atrasentan
11 DESCRIPTION VANRAFIA contains atrasentan, an endothelin type A (ET A ) receptor antagonist. The chemical name of atrasentan hydrochloride is (2 R , 3 R , 4 S )-4-(1,3-benzodioxol-5-yl)-1-[2-(dibutylamino)-2-oxoethyl]-2-(4-methoxyphenyl)-3-pyrrolidinecarboxylic acid hydrochloride. Atrasentan hydrochloride has a molecular weight of 547.09 g/mol, a molecular formula of C 29 H 38 N 2 O 6 HCl and the following structural formula.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.